Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications
Loading...
Date
2023-03-10
Authors
Siemaszko, Jagoda
Marzec-Przyszlak, Aleksandra
Bogunia-Kubik, Katarzyna
ORCID
Advisor
Referee
Mark
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
Altmetrics
Abstract
The interest in NK cells and their cytotoxic activity against tumour, infected or transformed cells continuously increases as they become a new efficient and off-the-shelf agents in immunotherapies. Their actions are balanced by a wide set of activating and inhibitory receptors, recognizing their complementary ligands on target cells. One of the most studied receptors is the activating CD94/NKG2C molecule, which is a member of the C-type lectin-like family. This review is intended to summarise latest research findings on the clinical relevance of NKG2C receptor and to examine its contribution to current and potential therapeutic strategies. It outlines functional characteristics and molecular features of CD94/NKG2C, its interactions with HLA-E molecule and presented antigens, pointing out a key role of this receptor in immunosurveillance, especially in the human cytomegalovirus infection. Additionally, the authors attempt to shed some light on receptor’s unique interaction with its ligand which is shared with another receptor (CD94/NKG2A) with rather opposite properties.
Description
Keywords
Citation
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2023, vol. 71, issue 1, p. 1-18.
https://link.springer.com/article/10.1007/s00005-023-00674-z
https://link.springer.com/article/10.1007/s00005-023-00674-z
Document type
Peer-reviewed
Document version
Published version
Date of access to the full text
Language of document
en